Prolor Biotech Inc., of Ness-Ziona, Israel, received a Notice of Allowance for a patent application for its long-acting CTP-enhanced human growth hormone, a method for decreasing body fat

Prolor Biotech Inc., of Nes Ziona, Israel, was issued a notice of allowance for its U.S

Prolor Biotech Inc., of Nes Ziona, Israel, was issued a notice of allowance for a patent application related to its long-acting reversible-pegylation technology, or RPeg platform, which the company is using to develop therapeutic peptides and small molecules

Prolor Biotech Inc., of Nes Ziona, Israel, received a notice of allowance for a patent covering its long-acting CTP-enhanced human growth hormone, specifically relating to methods for the induction of growth in growth hormone-deficient patients

Marina Biotech Inc., of Bothell, Wash., received a notice of allowance for a patent broadly claiming multiple sequence-independent and length-independent nucleic acid constructs having one or more unlocked nucleobase analogues

Prolor Biotech Inc., of Nes-Ziona, Israel, received a notice of allowance for a patent covering its CTP-modified interferons

Marina Biotech Inc., of Bothell, Wash., received a notice of allowance for a patent covering a library of more than 1x10(15) peptides...Prolor Biotech Inc., of Nes-Ziona, Israel, received a notice of allowance for a patent covering its long-acting CTP-enhanced human growth hormone

Prolor Biotech Inc., of Nes-Ziona, Israel, received a notice of allowance for a patent covering its CTP platform, specifically CTP-modified compositions of a wide array of classes of therapeutic proteins, including hormones, high-affinity protein ligands, proteins that induce or regulate an immune response, proteins involved with autocrine and paracrine activities and mimetics of those proteins

Marina Biotech Inc., of Bothell, Wash., received a notice of allowance for the patent application covering its DiLA2 delivery platform

Marina Biotech Inc., of Bothell, Wash., received a notice of allowance for a patent covering amphoteric liposomal formulations, including the firms' Smarticles technology, for delivery of siRNAs and other compounds with therapeutic application...Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No

Marina Biotech Inc., of Bothell, Wash., received U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, received U.S. Patent No

Prolor Biotech Inc., of Nes-Ziona, Israel, was issued two new U.S

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was issued U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No